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Abstract Collectins are C-type lectins which have been implied 
to play an important role in the innate immune defence against 
microorganisms. The critical discriminatory event in the 
opsonization of microorganisms by collectins is the interaction 
of the C-type lectin domain with microbial carbohydrates. 
Surface plasmon resonance measurements allow for quantitative 
real-time measurements of binding interaction between immobil- 
ized carbohydrate and unlabelled lectin in solution. Binding 
analysis were carried out with purified collectin-43 (CL-43) 
which structurally is the simplest collectin consisting of only 
three polypeptides each terminating in a C-type lectin domain. 
The target was immobilized yeast mannan. The molecular mass 
of native CL-43 was determinated by mass spectroscopy to 99.8 
kDa. The dissociation rate (kdiss) of the C-type lectin-carbohy- 
drate binding was fast (1.19-1.36×10 2 second 1), and the 
association rate (ka~) was 4.37-5.07 × l0 s M t second 1. The 
equilibrium constant for dissociation (Kd) was 2.68-2.72 × 10 s 
M. 
Key words: Collectin-43; C-type lectin; Affinity; Kinetics; 
BIAcore 
1. Introduction 
hydrate recognition domain (CRD). The collagen-like region 
of three polypeptides forms a stalk-like structure which is 
followed by a c~-helical coiled-coil neck region and three in- 
dependent folding globular CRDs [16]. The crystal structure 
of MBL CRD showed that asparagine and glutamine residues 
interact with the equatorial 3 and 4 hydroxyl groups of man- 
nose as well as with the calcium ion involved in ligand binding 
through coordination bonds. Binding studies have shown that 
the collectins generally bind carbohydrates with equatorial 3 
and 4 hydroxyl groups such as mannose and glucose, but also 
L-fucose which contains equatorial 2 and 3 hydroxyl groups 
that can be superimposed on the 3 and 4 hydroxyl group of 
mannose [16]. The five residues involved in the carbohydrate 
and calcium interaction, as judged from the crystal structure, 
are conserved between the collectins. Nevertheless, the relative 
affinities for monosaccharides, as judged by inhibition of 
binding to mannan, vary considerably [17]. 
The cruciform collectins, conglutinin and SP-D, are com- 
posed of four trimeric subunits and the serpiform collectins 
MBL and SP-A of six subunits, while CL-43 is seen only as 
structures corresponding to a single subunit [18]. CL-43 thus 
seems ideally suited for kinetic analysis of interactions with 
carbohydrates by surface plasmon resonance. 
Collectin-43 (CL-43) is a member of the collectin family of 
proteins that play a role in the innate immune defense against 
microorganisms [1 3]. Five collectins have been identified: the 
pulmonary surfactant proteins SP-A, and SP-D; the plasma 
lectins, conglutinin, mannan-binding lectin (MBL), and CL- 
43. 
The collectins have been shown to bind to the surface of 
various micro-organisms and particles, and the critical dis- 
criminatory event in this process is the interaction of the C- 
type lectin domain of the collectins and microbial carbohy- 
drates [4-9]. One collectin, MBL, can enhance opsonization 
by activation of the classical pathway of complement in a 
C lq-  and antibody-independent way [10-13]. Conglutinin op- 
sonizes through binding to iC3b deposited onto the surface of 
micro-organisms [14]. The collagenous regions of the collec- 
tins are ligands for the collectin receptor on phagocytes and 
other cells [15]. 
The collectins are oligomeric lectins built of subunits com- 
posed of three identical polypeptides. Each polypeptide chain 
consists of a short N-terminal sequence, followed by a col- 
lagen-like regions, a short a-helical sequence, and the carbo- 
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2. Materials and methods 
2.1. Bt([Jbrs, reagents and equipment 
BIAcore system, sensor scip CM5, surfactant P20 and amine cou- 
pling kit containing N-hydroxysuccinimide (NHS), N-ethyl-N'(di- 
methylaminopropyl)carbodiimide (EDC) and I M ethanolamine-hy- 
drochloride (pH 8.5) were obtained from Pharmacia Biosensor AB, 
Uppsala, Sweden. Mannan was purified from Saccharomyces cerevi- 
siae according to [19]. Tris-buffered saline (TBS): 140 mM NaC1, 10 
mM Tris-HCl, 2 mM NaN:~ (pH 7.2). TBS/Tw: TBS containing 0.05% 
Iv/v) Tween 20 (polyoxyethylene sorbitan monolaurate, Merck-Schu- 
chardt, FRG). HBS (10 mM HEPES, 0.15 M NaCI, 0.05% Surfactant 
P20) (pH 7.4). HBS-EDTA: HBS containing 10 mM EDTA. HBS- 
Ca~*: HBS containing 5 mM CaC12. Buffer A: 10 mM Tris, 10 mM 
EDTA, 0.05% (v/v) Emulphogene (BC 720, Sigma, St. Louis, MO, 
USA) (pH 7.5). 
Rabbit anti-bovine lgG (heavy and light chains) (Code Z249, Da- 
kopatts A/S, Kamstrup, Denmark) was coupled to CNBr-activated 
Sepharose 4B (Pharmacia, Sweden) at a concentration of 2.5 mg anti- 
body per ml gel. 
2.2. SDS-PAGE 
Electrophoresis was performed on 4-20% (w/v) polyacrylamide gra- 
dient gels with the discontinuous buffers described in [20]. Samples 
were reduced by heating at 100°C for 3 min in 40 mM dithiothreitol, 
1.5% (w/v) SDS, 5% (v/v) glycerol, 0.1 M Tris (pH 8.0), and carbox- 
amidated by the addition of iodoacetamide to a concentration of 90 
mM. Unreduced samples were heated in sample buffer with 90 mM 
iodoacctamide. Protein bands were detected by Coomassie blue stain- 
ing. 
All rights reserved. 
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2.3. Purification of CL-43 
Purification of CL-43 was modified from the previously described 
method [17]. The purification was carried out on a computer-moni- 
tored FPLC system (FPLCdirector Version 1.3, Pharmacia). The eu- 
globulins from one liter of bovine serum were precipitated with 4% 
(w/v) of PEG 6000 by incubation on ice for 1 h. After centrifugation 
(2000 × g, 15 min), the precipitate was washed with 600 ml of 6% (w/v) 
PEG 6000 in TBS containing 5 mM CaCIg. After further centrifuga- 
tion the precipitate was dissolved in 100 ml TBS containing 5 mM 
CaCI~ and passed through a column containing 100 ml of mannan- 
Sepharose. The mannan-Sepharose column was washed extensively 
(until E2s0 < 0.005), and bound proteins were eluted with TBS con- 
taining 2 mM GlcNAc, and then with 50 mM mannose. Fractions 
containing CL-43 were then passed through a column containing 15 
ml rabbit anti-bovine-Ig-Sepharose in order to remove contaminating 
anti-mannan antibodies. The effluent containing CL-43 was pooled, 
diluted 10 times in buffer A and applied to a Resource Q column (1 ml 
prepacked column, Pharmacia) and eluted with a gradient from 0 to 
100 mM NaCI in buffer A. CL-43 was eluted at 20 mM NaCI, CL-43 
containing fractions were then passed through a 7.5-ml TSK-mannose 
column. After wash the column was eluted with linear mannose gra- 
dients first from 0-6 mM mannose and then from 6 100 mM man- 
nose. CL-43 eluted at 3 mM mannose. CL-43 was further purified by 
gel permeation chromatography on a Superose 6 column (1.6 × 58 cm, 
Pharmacia). The fractions containing CL-43 were identified by SDS- 
PAGE, and the concentration of CL-43 in the purified preparation 
was estimated by quantitative amino acid analysis. 
2.4. Mass spectrometry 
The exact molecular mass of native CL-43 was obtained by matrix- 
assisted laser desorption mass spectrometry (MALDI-MS). Approx. 
100 pmol of intact CL-43 in 0.1 M ammoniumbicarbonate were ana- 
lyzed by MALDI-MS. 
2.5. Preparation of sensor surjaces 
Immobilization of mannan to sensor chip CM5 was performed in 
the biosensor system as described previously [21]. A continuous flow 
of 5 ~l/min was maintained. Between reagent injections the flow was 
maintained with HBS. The carboxylated dextran matrix was activated 
by injecting of 35 ~tl of a freshly made mixture of 70 ~tl 100 mM NHS 
and 70 ~tl 400 mM EDC. Next, 35 ~tl of mannan (700 ~tg/ml in 10 mM 
formic acid, pH 3.4) was injected followed by 35 I11 ethanolamine to
block the remaining NHS-ester groups. After conditioning with 0.1 M 
glycine-HC1 (pH 2.4), HBS-EDTA, HBS-Ca 2+, the sensor surface was 
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Fig. 1. SDS-PAGE of reduced (lane 1) and non-reduced (lane 2) 
CL-43 on a 4-20% (w/v) gradient gel stained by Coomassie blue. 
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Fig. 2. Mass spectroscopy of native CL-43. Approx. 100 pmol of in- 
tact CL-43 were analyzed by assisted laser desorption mass spectro- 
metry. The spectrum shows the singly, doubly and triply charged 
ions of the intact triple-chain molecule. The small peak at m/z 
66783 most likely represents a small amount of two-chain CL-43 
present in the preparation. 
ready to use. The immobilization level was 3500-4000 refractory units 
(RU). 
As a control recombinant CD4 (a gift from Nell Barkley) was im- 
mobilized to the carboxylated dextran matrix instead of mannan. 
2.6. Interaction of covalently immobilized yeast mannan with CL-43 
Purified CL-43 at various concentrations in the range of 0.62 5.0 
lag/ml (6.2 nM-50 nM) (concentration with regard to structural unit 
composed of three polypeptide chains with a molecular mass of 99.8 
kDa) in HBS-Ca 2+ was injected and allowed to react with immobil- 
ized mannan. A flow rate of 5 ~tl/min was maintained and 25 ~tl of 
CL-43 solution was injected. The analytical cycle was followed by a 
l-min injection of HBS-EDTA which regenerated the surface com- 
pletely. During each regeneration less than 0.1% of RU was lost. 
3. Results and discussion 
CL-43 was purified by PEG precipitation, sugar affinity 
chromatography using step-wise lution with GlcNAc to re- 
move conglutinin and gradient elution with mannose to sepa- 
rate CL-43 from bovine MBP. Anti-carbohydrate antibodies 
were removed by affinity chromatography. CL-43 was further 
purified by ion-exchange chromatography and size separation 
chromatography. The purified CL-43 is shown in Fig. 1. 
The cDNA of CL-43 encodes a polypeptide of 301 amino 
acid residues, with a molecular mass of the single polypeptide 
of 31.5 kDa as estimated from the sequence [22]. The appar- 
ent size of the CL-43 polypeptide chain as judged by SDS- 
PAGE is 43 kDa, and the covalent oligomer seen under non- 
reducing conditions is 120 kDa [17]. This is in agreement with 
the estimate of 119 138 kDa seen by sucrose-density gradient 
centrifugation and gel chromatography under non-denaturing 
conditions [18]. No oligomers of the structural unit were seen 
by gel permeation chromatography or sucrose-density gradi- 
ent centrifugation, consistent with the observation of only 
single units of three peptides by electron microscopy [18]. 
In order to obtain the exact molecular mass of CL-43, we 
analyzed the native molecule by mass spectroscopy (Fig. 2). 
The molecular mass of intact CL-43 was 99.8 Da. The differ- 
ence between the calculated mass of 94.5 kDa (based on 
cDNA) and the mass of 99.8 kDa found by mass spectroscopy 
must primarily be due to hydroxylations of prolines and ly- 
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Fig. 3. Kinetic binding curves (sensorgrams) of CL-43 binding to a 
biosensor surface coupled with mannan. Four different binding ex- 
periments were done at the concentrations of 50 nM, 25 riM, 12.5 
nM, 6.2 nM. The binding curves are expressed as resonance units 
(RU) as a function of time. The first arrow indicates the initiation 
of the injection of CL-43, and the second indicates the beginning of 
the buffer washout. 
sines and to O-linked carbohydrates, since no potential N- 
hydroxylat ion site is found in the CL-43 sequence. The mole- 
cular mass of 99.8 kDa was used for the calculation of the 
molar concentrat ion of CL-43. 
The surface plasmon response during the analytical cycle of 
CL-43 injection, binding to and dissociation from mannan is 
shown in Fig. 3, with different CL-43 concentrat ions pre- 
sented as overlay plots. 
The kinetic analysis using a 'one-receptor model'  revealed a 
moderate to fast association rate (k~)  4.37-5.07x 10 '~ M 1 
s -1, and a very rapid dissociation rate (kdi~) (1.19-1.36 × 10 2 
s -1) leading to a calculated value for the dissociation constant 
(Kd) of 2.68-2.72X 10 -8 M. No binding was seen when CL-43 
was passed over a CD4 matrix (data not shown). 
The rapid off-rate could indicate that the interaction of one 
subunit with three CRD would have insufficient ime to trig- 
ger an effector-mediated response. Multiple binding of several 
CL-43 molecules to repetitive carbohydrate moieties on the 
surface of the microorganism ay compensate for this rapid 
off-rate. For  the closely related collectins SP-D and congluti- 
nin a decreased effective off-rate could be achieved by multi- 
valent binding of the up to 12 CRD in a single molecule, and 
the dissociation constant (Kd) of the binding between human 
MBL and 12~I-mannan has been estimated to be 2 .3×10 '~ 
[23]. In this case up to 18 CRDs are involved in the binding. 
So far CL-43 has only been shown to bind to the acapsular 
form of Cryptocoecus neoformans [9], but the sugar binding 
profile of the molecule indicates, that CL-43, like the other 
collectins, will bind to carbohydrate moieties on the surface of 
a variety of microorganisms, after which the binding to the 
collectin receptor could mediate the binding and internaliza- 
tion of the CL-43 opsonized microorganisms. 
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